Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 7
1990 2
1992 3
1993 3
1994 2
1995 4
1996 5
1997 9
1998 2
1999 4
2000 2
2001 1
2002 9
2003 2
2004 7
2005 7
2006 9
2007 6
2008 11
2009 13
2010 21
2011 16
2012 15
2013 12
2014 15
2015 16
2016 15
2017 11
2018 12
2019 13
2020 21
2021 22
2022 15
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
Herbst SA, Vesterlund M, Helmboldt AJ, Jafari R, Siavelis I, Stahl M, Schitter EC, Liebers N, Brinkmann BJ, Czernilofsky F, Roider T, Bruch PM, Iskar M, Kittai A, Huang Y, Lu J, Richter S, Mermelekas G, Umer HM, Knoll M, Kolb C, Lenze A, Cao X, Österholm C, Wahnschaffe L, Herling C, Scheinost S, Ganzinger M, Mansouri L, Kriegsmann K, Kriegsmann M, Anders S, Zapatka M, Del Poeta G, Zucchetto A, Bomben R, Gattei V, Dreger P, Woyach J, Herling M, Müller-Tidow C, Rosenquist R, Stilgenbauer S, Zenz T, Huber W, Tausch E, Lehtiö J, Dietrich S. Herbst SA, et al. Among authors: gattei v. Nat Commun. 2022 Oct 20;13(1):6226. doi: 10.1038/s41467-022-33385-8. Nat Commun. 2022. PMID: 36266272 Free PMC article.
Integrin Signaling Shaping BTK-Inhibitor Resistance.
Polcik L, Dannewitz Prosseda S, Pozzo F, Zucchetto A, Gattei V, Hartmann TN. Polcik L, et al. Among authors: gattei v. Cells. 2022 Jul 18;11(14):2235. doi: 10.3390/cells11142235. Cells. 2022. PMID: 35883678 Free PMC article. Review.
Measurable residual disease in chronic lymphocytic leukemia.
Benintende G, Pozzo F, Innocenti I, Autore F, Fresa A, D'Arena G, Gattei V, Lurenti L. Benintende G, et al. Among authors: gattei v. Front Oncol. 2023 Feb 14;13:1112616. doi: 10.3389/fonc.2023.1112616. eCollection 2023. Front Oncol. 2023. PMID: 36865804 Free PMC article. Review.
Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C, Mauro E, Ermacora A, Doretto P, Fumagalli S, Tonizzo M, Toffolutti F, Gattei V. Mazzaro C, et al. Among authors: gattei v. Minerva Med. 2021 Apr;112(2):175-187. doi: 10.23736/S0026-4806.20.07120-7. Epub 2020 Nov 16. Minerva Med. 2021. PMID: 33198444 Review.
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature.
Mazzaro C, Bomben R, Visentini M, Gragnani L, Quartuccio L, Saccardo F, Sebastiani M, Filippini D, Lauletta G, Monti G, Gattei V. Mazzaro C, et al. Among authors: gattei v. Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780. eCollection 2023. Front Oncol. 2023. PMID: 36824142 Free PMC article. Review.
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Morabito F, Tripepi G, Mauro FR, Laurenti L, Reda G, Moia R, Condoluci A, Vincelli I, Chiarenza A, Vigna E, Martino EA, Bruzzese A, Mezzatesta S, Laureana R, Cutrona G, Di Raimondo F, Fronza G, Zucchetto A, Bomben R, Rossi FM, Olivieri J, Zaja F, Rossi D, Gaidano G, Del Principe MI, Ilariucci F, Del Poeta G, Ferrarini M, Neri A, Gattei V, Gentile M. Morabito F, et al. Among authors: gattei v. Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17. Am J Hematol. 2023. PMID: 37067157 No abstract available.
288 results